期刊文献+

半乳糖凝集素3及骨桥蛋白在非小细胞肺癌亚临床转移中的意义 被引量:8

The expression of galectin-3 and steopontin in occult metastasis of non-small cell lung cancer
原文传递
导出
摘要 目的研究半乳糖凝集素-3(Gal-3)和骨桥蛋白(OPN)在非小细胞肺癌(NSCLC)中的表达及其与亚临床转移的关系。方法选取2006年1月至2007年10月接受外科治疗的NSCLC患者46例,男性28例,女性18例,年龄33—77岁。应用RT—PCR及ELISA分别检测患者肺癌组织和血浆中Gal-3和OPN的表达,并结合术后随访,对肿瘤转移组和非转移组进行比较。结果46例NSCLC患者中,12例术后出现肿瘤转移。转移组血浆Gal-3水平为(18.8±7.9)ug/L,高于非转移组的(9.2±5.6)ug/L。转移组血浆OPN为(153.5±63.5)ug/L,高于非转移组的(89.2±24.0)ug/L。转移组癌组织中Gal-3 mRNA含量为0.73±0.23,OPN mRNA含量为0.79±0.24,均高于非转移组(0.07±0.17和0.17±0.25)。结论Gal-3和OPN是NSCLC的一种重要负性预后因素。血浆中Gal-3和OPN的高表达有可能成为判断NSCLC亚临床转移的有效指标之一。 Objective To study the relationship between expression of galectin-3 (Gal-3) and osteopontin (OPN) in occult metastasis in non-small cell lung cancer. Methods Forty-six patients of non-small cell lung cancer (NSCLC) from January 2006 to October 2007 were selected. There were 28 males and 18 females, aged from 33 to 77 years old. The levels of lung tissues Gal-3 and OPN were detected by RT-PCR, and the levels of blood plasma's were measured by ELISA. Results There were 12 patients who had metastasized. In un-metastasis group the Gal-3 and OPN mRNA expression levels were significantly lower than that in metastasis group: mean value were 0. 07 ±0. 17 and 0. 17±0.25 in un-metastasis group, while 0. 73 ~ 0. 23 and 0. 79 ± 0. 24 in metastasis group. Blood plasm levels of Gal-3 ( 18. 8 ± 7. 9 )ug/L and OPN ( 153.5± 63.5 )ug/L in NSCLC which were detected from metastasis group were higher than un-metastasis group of (9. 2 ± 5.6 ) ug/L and ( 89.2 ± 24. 0 ) ug/L. Conclusions High serum levels of Gal-3 and OPN and high expression of Gal-3 and OPN mRNA in NSCLC are closely related to the occurrence and metastasis of NSCLC. They may be indexes of evaluating the occult metastasis in NSCLC.
出处 《中华外科杂志》 CAS CSCD 北大核心 2009年第14期1061-1063,共3页 Chinese Journal of Surgery
基金 北京市教育委员会科技发展计划面上项目(km200710025019)
关键词 非小细胞肺 肿瘤转移 半乳糖凝集素3 骨桥蛋白质 Carcinoma, non-small-cell lung Neoplasm metastasis Galectin 3 Osteopontin
  • 相关文献

参考文献8

  • 1Liu FT,Hsu DK,Zuberi RI,et al.Expression and function of galectin-3,a beta-galacteside-binding lactin,in human monocytes and macrophages.Am J Pathol,1995,147:1016-1028.
  • 2Thodou E,Argyrakos T,Kontogeorgos G.Galectin-3 as a marker distinguishing functioning from silent corticotroph adenomas.Hormones (Athens),2007,6:227-232.
  • 3Yu LG,Andrews N,Zhao Q,et al.Galectin-3 imeraction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion.J Biol Chem,2007,282:773-781.
  • 4Baldus SE,Zirbes TK,Weingarten M,et al.Increased galectin-3 expression in gastric cancer:correlations with histopathological subtypes,galactosylated antigens and tumor cell proliferation.Turnout Biol,2000,21:258-266.
  • 5Coppola D,Szabo M,Boulware D,et al.Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies.Clin Cancer Res,2004,10:184-190.
  • 6Fukumori T,Takenaka Y,Oka N,et al.Endogenous galectin-3 determines the muting of CD95 apoptotic sigaling pathway& Cancer Res,2004,64:3376-3379.
  • 7Nangia-Makker P,Honjo Y,Sarvis R,et al.Galectin-3 induces endothelial cell morphogenesis and ongiogenesis.Am J Pathol,2000,156:899-909.
  • 8Grazio S,Korsi c M,Jaji c I.Effects of smoking and alcohol consumption on vertebral deformity in the alderly-an epidemiological study.Coll Antropol,2005,29:567-572.

同被引文献56

  • 1邢雪花,刘华,谢贤和,王蔚,郑垂志,陈俊民.多西紫杉醇联合卡铂治疗晚期非小细胞肺癌疗效观察[J].中国热带医学,2007,7(8):1332-1333. 被引量:7
  • 2Jemal A, Center MM,DeSantis C,et al. Global patterns of cancer in-cidence and mortality rates and trends [ J]. Cancer Epidemiol Bio-markers Prew,2010,19:1893 - 1907.
  • 3Ramalingma SS,Owonikoko TK,Khuri FR. Lung cancer:new biologi-cal insights and recent therapeutic advances[ J]. CA Cancer J Clin,2011,61: 91 -112.
  • 4Tsuboi K, Shimura T, Masuda N, et al. Galectin -3 expression incolorectal cancer : relation to invasion and metastasis [ J ]. AnticancerRes ,2007,27:2289 - 2296.
  • 5Langmesser S, Tallone T, Bordon A, et al. Interaction of circadianclock protein PER2 and CRY with BMAL 1 and CLOCK[ J] . BMCMolBiol(2008, 9:41.
  • 6Sakaki M,Fukumori T,Fukawa T,et al. Clinical significance of Ga-lectin -3 in clear cell renal cell carcinoma [ J ]. Med Invest, 2010,57; 152 -157.
  • 7Rossi ED, Straccia P, Palumbo M, et al. Diagnostic and prognosticrole of HBME - 1,galectin - 3,and p - catenin in poorly differenti-ated and anaplastic thyroid carcinomas[ J]. Appl Immuno HistochemMol Morphol, 2013, 21(3) :237 -241.
  • 8Kubo T, Ozasa K, Mikami K,et al. Prospective cohort study of therisk of prostate cancer among rotating - shift workers ; findings fromthe Japan collaborative cohort study [ J ]. Am J Epidemiol,2006,164:549 -555.
  • 9Langmesser S,Tal lone T,Bordon A,et al. Interaction of circ - adianclock protein mPer2 and CRY with Bmal 1 and Clock [ J] . BMCMel Biol,2008.9:41.
  • 10Stevens RG. Circadian disruption and breast cancer : from me - Iato-nin to clock genes[ J]. Epidemiology ,2005,16:254 -258.

引证文献8

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部